Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
10.56B | 12.00B | 12.70B | 14.58B | 15.02B | Gross Profit |
4.12B | 4.98B | 5.28B | 6.19B | 7.05B | EBIT |
1.53B | 2.31B | 1.63B | 2.38B | 2.53B | EBITDA |
1.59B | 2.79B | 1.74B | 175.95M | 2.90B | Net Income Common Stockholders |
1.04B | 1.96B | 1.48B | -2.92B | 2.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.15B | 6.89B | 10.62B | 8.43B | 10.93B | Total Assets |
18.38B | 16.23B | 15.83B | 18.11B | 23.22B | Total Debt |
4.58B | 2.29B | 2.77B | 4.83B | 4.93B | Net Debt |
458.53M | -3.33B | -2.25B | -739.22M | 1.56B | Total Liabilities |
6.95B | 4.24B | 4.90B | 7.53B | 8.39B | Stockholders Equity |
11.43B | 11.80B | 10.93B | 10.59B | 14.84B |
Cash Flow | Free Cash Flow | |||
1.35B | 1.70B | 1.15B | 1.46B | 2.96B | Operating Cash Flow |
1.64B | 2.28B | 1.23B | 1.56B | 3.08B | Investing Cash Flow |
-558.89M | 2.41B | 1.72B | 2.55B | -748.47M | Financing Cash Flow |
236.20M | -1.70B | -3.43B | -1.79B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $25.58B | 20.46 | 14.37% | 1.00% | 4.59% | 83.27% | |
77 Outperform | $2.39B | 17.99 | 19.74% | ― | 5.93% | 29.17% | |
73 Outperform | $2.28B | 6.93 | 10.79% | 8.54% | 0.83% | 22.06% | |
65 Neutral | $997.68M | 7.76 | 9.01% | ― | -13.37% | -44.13% | |
60 Neutral | $14.12B | 6.43 | -3.56% | 3.69% | 2.49% | -35.43% | |
55 Neutral | $2.27B | ― | -2.96% | 2.12% | -1.33% | -148.56% | |
47 Neutral | $9.19B | 189.78 | -10.51% | ― | -98.74% | -128.03% |